AI assistant
Sending…
GENTEX CORP — Director's Dealing 2020
Sep 4, 2020
30893_dirs_2020-09-04_58f187fb-a36d-4c5d-ad34-a98a25f7ae34.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GENTEX CORP (GNTX)
CIK: 0000355811
Period of Report: 2020-09-02
Reporting Person: Downing Steven R (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-09-02 | Common Stock | M | 16200.00 | $12.795 | Acquired | 155259.00 | Direct |
| 2020-09-02 | Common Stock | M | 7500.00 | $13.385 | Acquired | 162759.00 | Direct |
| 2020-09-02 | Common Stock | S | 23700.00 | $28.0473 | Disposed | 139059.00 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-09-02 | Employee Stock Option (Right to Buy) | $13.385 | M | 7500.00 | Disposed | 2021-09-30 | Common Stock (7500.00) | Direct |
| 2020-09-02 | Employee Stock Option (Right to buy) | $12.795 | M | 16200.00 | Disposed | 2020-09-30 | Common Stock (16200.00) | Direct |
Footnotes
F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
F2: This transaction was executed in multiple trades at prices ranging from $28.02 to $28.09. The price reported above reflects the weighted average price.
F3: Options are fully vested.
More from GENTEX CORP
Interim / Quarterly Report
2026
May 6
Major Shareholding Notification
2026
Apr 30
Regulatory Filings
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Feb 24
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19